Cannabis use, abuse and dependence during the COVID-19 pandemic: a scoping review
U Bonnet, M Specka, P Roser, N Scherbaum - Journal of Neural …, 2023 - Springer
The interaction between cannabis use or addiction and SARS-COV-2 infection rates and
COVID-19 outcomes is obscure. As of 08/01/2022 among 57 evaluated epidemiological …
COVID-19 outcomes is obscure. As of 08/01/2022 among 57 evaluated epidemiological …
COVID-19 outcomes: Does the use of psychotropic drugs make a difference? Accumulating evidence of a beneficial effect of antidepressants—A scoping review
U Bonnet, G Juckel - Journal of Clinical Psychopharmacology, 2022 - journals.lww.com
COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a... : Journal of Clinical
Psychopharmacology COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a …
Psychopharmacology COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a …
Association between antidepressant use and ED or hospital visits in outpatients with SARS-CoV-2
Antidepressants have previously been associated with better outcomes in patients
hospitalized with COVID-19, but their effect on clinical deterioration among ambulatory …
hospitalized with COVID-19, but their effect on clinical deterioration among ambulatory …
[HTML][HTML] Academic Textbook: Diagnosis and Treatment of Manifestations of COVID-19
The diagnosis and treatment of manifestations of COVID-19 have evolved significantly since
the onset of the pandemic. With an expanding understanding of the virus and its impact on …
the onset of the pandemic. With an expanding understanding of the virus and its impact on …
Association of fluvoxamine with mortality and symptom resolution among inpatients with COVID-19 in Uganda: a prospective interventional open-label cohort study
BJ Kirenga, L Mugenyi, M Sánchez-Rico, H Kyobe… - Molecular …, 2023 - nature.com
Prior research suggests that fluvoxamine, a selective serotonin reuptake inhibitor (SSRI)
used for the treatment of obsessive-compulsive disorder and major depressive disorder …
used for the treatment of obsessive-compulsive disorder and major depressive disorder …
Mental disorders, COVID-19-related life-saving measures and mortality in France: A nationwide cohort study
M Schwarzinger, S Luchini, M Teschl, F Alla… - PLoS …, 2023 - journals.plos.org
Background Meta-analyses have shown that preexisting mental disorders may increase
serious Coronavirus Disease 2019 (COVID-19) outcomes, especially mortality. However …
serious Coronavirus Disease 2019 (COVID-19) outcomes, especially mortality. However …
Medications modulating the acid sphingomyelinase/ceramide system and 28-day mortality among patients with SARS-CoV-2: an observational study
Prior evidence indicates the potential central role of the acid sphingomyelinase
(ASM)/ceramide system in the infection of cells with SARS-CoV-2. We conducted a …
(ASM)/ceramide system in the infection of cells with SARS-CoV-2. We conducted a …
Association between FIASMA psychotropic medications and reduced risk of intubation or death in individuals with psychiatric disorders hospitalized for severe COVID …
N Hoertel, M Sánchez-Rico, E Gulbins… - Translational …, 2022 - nature.com
The acid sphingomyelinase (ASM)/ceramide system may provide a useful framework for
better understanding SARS-CoV-2 infection and the repurposing of psychotropic …
better understanding SARS-CoV-2 infection and the repurposing of psychotropic …
Serious mental illness and in-hospital mortality among hospitalized patients with acute COVID-19: A large-database analysis in Japan
Y Tokuda, PB Barnett, S Sanji, Y Takaizumi… - General Hospital …, 2023 - Elsevier
Objective The association of serious mental illness (affective or non-affective psychotic
disorders) with higher mortality in patients infected with acute coronavirus disease 2019 …
disorders) with higher mortality in patients infected with acute coronavirus disease 2019 …
Antidepressant use and its association with 28-day mortality in inpatients with SARS-CoV-2: support for the FIASMA model against COVID-19
To reduce Coronavirus Disease 2019 (COVID-19)-related mortality and morbidity, widely
available oral COVID-19 treatments are urgently needed. Certain antidepressants, such as …
available oral COVID-19 treatments are urgently needed. Certain antidepressants, such as …